6-Azauridine in combination chemotherapy of childhood acute myelocytic leukemia.
D000293:Adolescent; D000741:Anemia, Aplastic / Q000139:chemically induced; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D004338:Drug Combinations; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D012075:Remission, Spontaneous / Q000139:chemically induced; D014227:Triazines / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D004338:Drug Combinations; D014227:Triazines; D014750:Vincristine; D015122:Mercaptopurine